Michael S. Weiss
TG THERAPEUTICS
Chief Executive Officer and President
Overview
Michael S. Weiss received an average compensation of $8,250,210 at TG THERAPEUTICS from 2011 to 2017.
Annual data
2017
| Non-Equity Incentive Plan | $217,969 |
|---|---|
| Salary | $525,000 |
| Stock Awards | $9,183,647 |
| Total | $9,926,616 |
In 2017, Michael S. Weiss earned a total compensation of $9,926,616 as Chief Executive Officer and President at TG THERAPEUTICS, INC..
Weiss received $9,183,647 in stock awards, which accounts for 92.52% of total compensation.
Weiss also received $217,969 in non-equity incentive plan and $525,000 in salary.
2016
2015
2012
2011
Fortress Biotech
Executive Vice Chairman, Strategic Development
Overview
Michael S. Weiss received an average compensation of $5,277,307 at Fortress Biotech from 2014 to 2016.
Annual data
2016
| Non-Equity Incentive Plan | $500,000 |
|---|---|
| Salary | $29,689 |
| Stock Awards | $1,492,285 |
| Other | $72,015 |
| Total | $2,093,989 |
In 2016, Michael S. Weiss earned a total compensation of $2,093,989 as Executive Vice Chairman, Strategic Development at Fortress Biotech, Inc..
Weiss received $1,492,285 in stock awards, which accounts for 71.27% of total compensation.
Weiss also received $500,000 in non-equity incentive plan, $29,689 in salary and $72,015 in other compensation.
2015
2014
KERYX BIOPHARMACEUTICALS
Former Chairman and Chief Executive Officer
Overview
Michael S. Weiss received an average compensation of $4,302,891 at KERYX BIOPHARMACEUTICALS from 2006 to 2009.
Annual data
2009
| Option Awards | $263,585 |
|---|---|
| Salary | $273,085 |
| Stock Awards | $396,000 |
| Other | $666,705 |
| Total | $1,599,375 |
In 2009, Michael S. Weiss earned a total compensation of $1,599,375 as Former Chairman and Chief Executive Officer at KERYX BIOPHARMACEUTICALS INC.
Weiss received $666,705 in other compensation, which accounts for 41.69% of total compensation.
Weiss also received $263,585 in option awards, $273,085 in salary and $396,000 in stock awards.
2008
2007
2006